FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  China Grand Pharmaceutical & Healthcare Holdings Ltd
2. Date of Event Requiring Statement (Month/Day/Year)
02/07/2020
3. Issuer Name and Ticker or Trading Symbol
ONCOSEC MEDICAL Inc [ONCS]
(Last)
(First)
(Middle)
C/O CHAO ZHOU, UNIT 3302, 33/F,, THE CENTER, 99 QUEEN'S ROAD CENTRAL
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner
_____ Officer (give title below) __X__ Other (specify below)
See Remarks
5. If Amendment, Date Original Filed(Month/Day/Year)
02/18/2020
(Street)

HONG KONG,  
6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 12,000,000
I
See Footnote (1)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
China Grand Pharmaceutical & Healthcare Holdings Ltd
C/O CHAO ZHOU, UNIT 3302, 33/F,
THE CENTER, 99 QUEEN'S ROAD CENTRAL
HONG KONG 
    X   See Remarks
Grand Decade Developments Ltd
C/O CHAO ZHOU, UNIT 3302, 33/F,
THE CENTER, 99 QUEEN'S ROAD CENTRAL
HONG KONG 
    X   See Remarks
Sirtex Medical US Holdings, Inc.
300 UNICORN PARK DRIVE
WOBURN, MA 01801
    X   See Remarks

Signatures

/s/ Caterina Benson by Power of Attorney for China Grand Pharmaceutical and Healthcare Holdings Limited 02/19/2020
**Signature of Reporting Person Date

/s/ Caterina Benson by Power of Attorney for Grand Decade Developments Limited 02/19/2020
**Signature of Reporting Person Date

/s/ Caterina Benson by Power of Attorney for Sirtex Medical US Holdings, Inc. 02/19/2020
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) On October 10, 2019, OncoSec Medical Incorporated (the "Issuer") entered into Stock Purchase Agreements with each of Grand Decade Developments Limited ("Grand Decade"), a wholly owned subsidiary of China Grand Pharmaceutical and Healthcare Holdings Limited ("CGP"), (the "CGP Purchase Agreement") and Sirtex Medical US Holdings, Inc., an affiliate of CGP ("Sirtex"), (the "Sirtex Purchase Agreement", and together with the CGP Purchase Agreement, the "Purchase Agreements"). On February 7, 2020, the transactions set forth in the Purchase Agreements were consummated. Pursuant to the terms of the Purchase Agreements and for consideration paid by the Reporting Persons, the Issuer directly issued to Grand Decade and Sirtex 10,000,000 shares and 2,000,000 shares, respectively, of the Issuer's Common Stock.
 
Remarks:
The Reporting Persons may be deemed to be members of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended. Each Reporting Person disclaims beneficial ownership of any securities deemed to be owned by the group that are not directly owned by the Reporting Person. This report shall not be deemed an admission that such Reporting Person is a member of a group or the beneficial owner of any securities not directly owned by such Reporting Person.  This Amendment is filed solely to add EDGAR CIKs for certain reporting persons.

Exhibit List:

Ex. 24.1 - Power of Attorney

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.